Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.5K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
Tissue Transplantation01:24

Tissue Transplantation

834
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
834

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PREVALENCE OF HEPATITIS C VIRUS ANTIBODY IN HETEROGENEOUS POPULATION OF BLOOD DONORS.

Medical journal, Armed Forces India·2017
Same author

AUTOLOGOUS TRANSFUSION AFMC EXPERIENCE (1992-1996).

Medical journal, Armed Forces India·2017
Same author

STUDY OF WEAK D PHENOTYPE IN HETEROGENEOUS POPULATION.

Medical journal, Armed Forces India·2017
Same author

TRANSFUSION REACTIONS: AFMC EXPERIENCE.

Medical journal, Armed Forces India·2017
Same author

BRUNNEROMA - A RARE TUMOUR OF THE DUODENUM: A Case Report.

Medical journal, Armed Forces India·2017
Same author

Artifical Blood.

Medical journal, Armed Forces India·2016
Same journal

Healthcare costs of COVID-19 hospitalization in maintenance hemodialysis patients during the first two pandemic waves in Romania: a retrospective cohort study.

Journal of medicine and life·2026
Same journal

Clinical and inflammatory biomarkers predicting emergency surgical management decisions and postoperative outcomes in complicated colon cancer.

Journal of medicine and life·2026
Same journal

Antibiotic stewardship and safety in office-based transrectal prostate biopsy: a single-center retrospective analysis of complications.

Journal of medicine and life·2026
Same journal

Epigenetic mechanisms in preeclampsia: translational therapeutic strategies and precision-medicine perspectives.

Journal of medicine and life·2026
Same journal

Short-term functional outcome and pain assessment after spinal decompression for spondylodiscitis.

Journal of medicine and life·2026
Same journal

Effects of vitamin K administration on liver function, inflammation, and coagulation in chronic viral hepatitis: a retrospective study.

Journal of medicine and life·2026
See all related articles

Related Experiment Video

Updated: Jan 4, 2026

Experimental Approaches to Tissue Engineering
16:41

Experimental Approaches to Tissue Engineering

Published on: August 30, 2007

6.7K

Tissue Engineering; Current Status & Futuristic Scope.

Preeti Sharma1, Pradeep Kumar1, Rachna Sharma2

  • 1Department of Biochemistry, Santosh Medical College and Hospital (Santosh University), Ghaziabad, UP, India.

Journal of Medicine and Life
|November 1, 2019
PubMed
Summary
This summary is machine-generated.

Tissue engineering aims to regenerate tissues using cells, biomaterials, and growth factors. Clinical applications remain limited due to unresolved challenges in cell sources, scaffolds, and growth factor delivery, requiring further research and collaboration.

Keywords:
in born errorneonatestissue engeneering

More Related Videos

Core/shell Printing Scaffolds For Tissue Engineering Of Tubular Structures
05:52

Core/shell Printing Scaffolds For Tissue Engineering Of Tubular Structures

Published on: September 27, 2019

9.8K
Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber
09:55

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Published on: May 30, 2016

9.3K

Related Experiment Videos

Last Updated: Jan 4, 2026

Experimental Approaches to Tissue Engineering
16:41

Experimental Approaches to Tissue Engineering

Published on: August 30, 2007

6.7K
Core/shell Printing Scaffolds For Tissue Engineering Of Tubular Structures
05:52

Core/shell Printing Scaffolds For Tissue Engineering Of Tubular Structures

Published on: September 27, 2019

9.8K
Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber
09:55

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Published on: May 30, 2016

9.3K

Area of Science:

  • Regenerative Medicine
  • Biomaterials Science
  • Biotechnology

Background:

  • Tissue engineering, established nearly 30 years ago, offers a novel therapeutic approach to regenerate tissues.
  • It aims to overcome limitations of artificial organs and transplantation for replacing damaged or lost tissues.
  • Despite its potential, clinical applications are currently restricted to a few tissue types like skin, bone, and cartilage.

Purpose of the Study:

  • To provide an overview of the current status of tissue engineering.
  • To explore the fundamental components and applications of tissue engineering.
  • To identify critical challenges hindering broader clinical translation.

Main Methods:

  • Review of fundamental principles including cell sources, scaffold design, and growth factor delivery systems.
  • Analysis of data from animal and human trials for tissue-engineered products.
  • Engineering-focused perspective on current limitations and future directions.

Main Results:

  • Successful regeneration in limited tissues (skin, bone, cartilage, capillary, periodontal) highlights progress.
  • Significant challenges persist in scaling up and clinical translation of engineered tissues.
  • The field requires enhanced understanding and optimization of cell sources, scaffolds, and growth factor carriers.

Conclusions:

  • Tissue engineering holds promise but faces hurdles in clinical implementation.
  • Addressing challenges in cell sourcing, scaffold engineering, and growth factor delivery is crucial.
  • Close collaboration between medical professionals and biomaterials scientists is essential for advancing the field.